Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2, with no impact to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe Publications section now states that entries are auto-filled from PubMed and may not pertain to the study. It also adds the Revision: v3.3.2 label.SummaryDifference0.1%

- Check42 days agoChange DetectedThe 'Notice Because of a lapse in government funding...' banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedResults First Posted 2025-02-20 are now listed on the study record, and the Publications section has been updated with related articles. Study record dates, including primary completion, have been updated accordingly.SummaryDifference0.4%

- Check85 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference3%

- Check93 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.